Skip to main content
. 2019 Jul-Dec;9(2):71–77. doi: 10.5005/jp-journals-10018-1302

Table 1B.

Descriptive statistics for various parameters according to mortality

Parameters Mortality p value
No (n = 198) Yes (n = 34)
Age in years (mean ± SD) 50 ± 13 49 ± 10 0.684
Sex [no. (%)] Female 40 (20.2) 5 (14.71) 0.454
Male 158 (79.8) 29 (85.29)
Etiology [no. (%)] Alcohol 129 (65.1) 29 (85.3) 0.508
EHPVO 2 (1.0) 0 (0)
HBV 17 (85.8) 2 (5.9)
HBV + HCV 1 (0.5) 0 (0)
HCV 10 (5.1) 1 (2.9)
HIV + HBV 1 (0.5) 0 (0)
NAFLD 30 (15.1) 1 (2.9)
NCPF 8 (4.0) 1 (2.9)
GI bleed [no. (%)] No 125 (63.13) 28 (82.35) 0.029
Yes 73 (36.87) 6 (17.65)
Grade of varices [no. (%)] I 108 (54.5) 19 (55.8) 0.844
II 53 (26.7) 10 (29.4)
III 37 (18.7) 5 (14.7)
HE [no. (%)] No 153 (77.27) 14 (41.18) <0.0001
Yes 45 (22.73) 20 (58.82)
Hydrothorax [no. (%)] No 186 (93.94) 26 (76.47) 0.001
Yes 12 (6.06) 8 (23.53)
HRS [no. (%)] No 173 (87.37) 14 (41.18) <0.0001
Yes 25 (12.63) 20 (58.82)
PVT [no. (%] No 156 (78.79) 20 (58.82) 0.012
Yes 42 (21.2) 14 (41.18)
HCC [no. (%)] No 192 (96.97) 23 (67.65) <0.0001
Yes 6 (3.03) 11 (32.35)

SD, standard deviation; HBV, hepatitis B virus; HCV, hepatitis C virus; GI, gastrointestinal; HE, hepatic encephalopathy; HRS, hepatorenal syndrome; PVT, portal vein thrombosis; HCC, hepatocellular carcinoma; EHPVO, extrahepatic portal vein obstruction; NAFLD, nonalcoholic fatty liver disease; NCPF, noncirrhotic portal fibrosis

p values in boldface indicate statistical significance